What milestone did Intralytix achieve in 2006 regarding the use of phages in human health applications?

A. Performed the first-in-human clinical trial using phages to treat infected venous ulcers
B. Conducted the first preclinical trial of phage-based products
C. Received FDA approval for a phage-based product
D. Completed Phase 3 clinical trials of phage-based products
Answer: 